BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 11426464)

  • 21. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
    Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
    J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.
    Mitani K; Graham FL; Caskey CT; Kochanek S
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3854-8. PubMed ID: 7731995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
    Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
    Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AdEasy-based cloning system to generate tropism expanded replicating adenoviruses expressing transgenes late in the viral life cycle.
    Lie-A-Ling M; Bakker CT; Wesseling JG; Bosma PJ
    Gene Ther; 2005 Sep; 12(17):1347-52. PubMed ID: 15877046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
    Alemany R; Dai Y; Lou YC; Sethi E; Prokopenko E; Josephs SF; Zhang WW
    J Virol Methods; 1997 Nov; 68(2):147-59. PubMed ID: 9389404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro.
    Aoki K; Barker C; Danthinne X; Imperiale MJ; Nabel GJ
    Mol Med; 1999 Apr; 5(4):224-31. PubMed ID: 10448644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.
    Parks RJ; Bramson JL; Wan Y; Addison CL; Graham FL
    J Virol; 1999 Oct; 73(10):8027-34. PubMed ID: 10482551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular adenovirus gene transfer varies in efficiency and inflammatory response.
    Borrás T; Tamm ER; Zigler JS
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1282-93. PubMed ID: 8641831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration.
    Parks R; Evelegh C; Graham F
    Gene Ther; 1999 Sep; 6(9):1565-73. PubMed ID: 10490766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
    Brunetti-Pierri N; Ng P
    Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel and simple method for rapid generation of recombinant porcine adenoviral vectors for transgene expression.
    Zhang P; Du E; Ma J; Wang W; Zhang L; Tikoo SK; Yang Z
    PLoS One; 2015; 10(5):e0127958. PubMed ID: 26011074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method.
    Mizuguchi H; Kay MA
    Hum Gene Ther; 1998 Nov; 9(17):2577-83. PubMed ID: 9853524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of the helper-dependent adenovirus system for production and potency in vivo.
    Sandig V; Youil R; Bett AJ; Franlin LL; Oshima M; Maione D; Wang F; Metzker ML; Savino R; Caskey CT
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1002-7. PubMed ID: 10655474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
    Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
    Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.
    Miyake S; Makimura M; Kanegae Y; Harada S; Sato Y; Takamori K; Tokuda C; Saito I
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1320-4. PubMed ID: 8577762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.
    Prince HM; Dessureault S; Gallinger S; Krajden M; Sutherland DR; Addison C; Zhang Y; Graham FL; Stewart AK
    Exp Hematol; 1998 Jan; 26(1):27-36. PubMed ID: 9430511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of portable intron cassettes for the delivery and expression of foreign genes.
    Reilly JD; Silva RF
    DNA Cell Biol; 1996 Dec; 15(12):1113-20. PubMed ID: 8985125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.